Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof
US8822482B2 · kind B2 · utility
1Cited by
0References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 7, 2009 |
| Grant date | Sep 2, 2014 |
| Priority date | — |
| Expiry date | Apr 17, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-quinazoline hydrochloride, its new crystalline forms, its therapeutic usage for treatment of diseases mediated by EGFR kinase and its combinatory therapeutic usage together with other therapeutic agents. The invention also provides synthetic methods for preparation of 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-quinazoline hydrochloride, its new crystalline forms, and the relevant synthetic intermediates for synthesis of 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-quinazoline hydrochloride.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.